---
document_datetime: 2026-01-13 15:30:51
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/welireg-epar-all-authorised-presentations_en.pdf
document_name: welireg-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6436719
conversion_datetime: 2026-01-14 08:35:22.626253
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.68.0
  docling-core: 2.59.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size           |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------|
| EU/1/24/1893/002 | Welireg           | 40 mg      | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 90 (3 x 30) tablets |